Notice ID: 17ebb6c225264658906ccb2e93f65c0bAward NoticeAwarded
Genotyping Services for Transgenic Rats and Mice for HIV Project
Awarded on August 8, 2023. Full description on SAM.gov.
Awarded tounder 75N95023P00520 (source: SAM.gov award notice)• $30.0K
Overview
- Posted
- August 8, 2023
- Notice type
- Award Notice
- NAICS
- 541380: Testing Laboratories and Services
- Agency
- Department of Health and Human Services
Notice details
- Place of performance
- Bethesda, MD, 20892
- Last updated
- Dec 4, 2025
- Award date
- Aug 8, 2023
- Award amount (SAM.gov award notice)
- $30.0K
Identifiers
- Solicitation number
- 75N95023P00520
- Notice ID
- 17ebb6c225264658906ccb2e93f65c0b
- Award number (PIID)
- 75N95023P00520
Description
NOTICE OF AWARD. THIS IS NOT A REQUEST FOR QUOTE/PROPOSALS. On August 8, 2023, in response to the requirements of Solicitation 75N95023Q00368, the National Institute on Drug Abuse (NIDA) awarded Purchase Order No. 75N95023P00520 to Transnetyx, Inc. to acquire Genotyping Services for Transgenic Rats and Mice for HIV Project. An award shall be made on a Firm-Fixed-Price basis. Funding in the amount of $30,000.00 shall be obligated to fully fund this award.
Award Overview
Award Number
75N95023P00520
Award Amount (SAM.gov award notice)
$30.0K
Award Date
Aug 8, 2023
Awardee
Awardee UEI
CNG6DGADGL38
Original Solicitation
Notice ID: 17ebb6c225264658906ccb2e93f65c0b
Posted Date: Aug 8, 2023
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- $1.1MSigned Aug 14, 2026
- $200.0KSigned Aug 12, 2026
- $425.6KSigned Aug 12, 2026
- $176.4KSigned Aug 5, 2026
- $167.7KSigned Aug 5, 2026
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N95023P00520- Awarded
This opportunity has been awarded.
- AwardedCurrentAug 8, 2023
Genotyping Services for Transgenic Rats and Mice for HIV Project
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Centers for Disease Control (CDC) is issuing this synopsis as a means of conducting market research to identify parties having an interest in and the resources to support this requirement for a California-based integrated health care system to serve as an electronic health record site in CDC’s VISION 2.0 respiratory pathogen surveillance network, providing integrated, longitudinal medical, laboratory, pharmacy, vaccination, claims, and outcomes data to support influenza surveillance, vaccine-effectiveness studies, and related respiratory pathogen research across emergency/urgent care, inpatient, and intensive care unit (ICU) settings. The result of this market research will contribute to determining the method of acquisition. The applicable North American Industry Classification System (NAICS) code assigned to this acquisition is 541380- Testing Laboratories and Services. | 61% | Market Research | 12/04/2026 |
Husbandry Animal Services | 57% | Market Research | 11/09/2026 |
Louisville VAMC seeks a contract for laboratory services to run surface sample testing and personnel aseptic technique competency testing results (gloved fingertip and thumb sampling and media fill testing) for the Pharmacy Service s sterile compounding spaces. **Solicitation closing will be moved to WED 11/04/2026 @ 1500 EST. | 57% | Solicitation | 11/04/2026 |
The South Texas Veterans Health Care System requires contractor services to perform testing and certification of sterile compounding facilities, including primary and secondary engineering controls as described in the attached Performance Work Statement (PWS), at the Audie L. Murphy Memorial VA Hospital Pharmacy Service. All work shall be performed in accordance with applicable standards and the related testing described in the attached PWS. The contractor shall provide all labor, equipment, and documentation needed to fulfill the requirements outlined in the PWS. | 57% | Combined Synopsis | 11/17/2026 |
Louisville VAMC seeks a contract for laboratory services to run surface sample testing and personnel aseptic technique competency testing results (gloved fingertip and thumb sampling and media fill testing) for the Pharmacy Service s sterile compounding spaces. | 57% | Pre-Solicitation | 11/02/2026 |
Additional Details
Solicitation Number
75N95023P00520
Archive Date
Aug 23, 2023
Office Address
Bethesda, MD, 20892